Viewing Study NCT02048059

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:44 PM
Ignite Modification Date: 2026-05-26 @ 5:56 PM
Study NCT ID: NCT02048059
Status: COMPLETED
Last Update Posted: 2020-02-25
First Post: 2014-01-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases
Sponsor: Angiochem Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Brain Metastases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ANG1005 View
None GRN1005 View
None Low-density lipoprotein receptor-related protein (LRP-1) View
None Targeted therapy View
None Breast cancer View
None Brain metastases View
None Brain tumor View
None Blood-brain barrier View
None Trastuzumab View
None Herceptin View
None Paclitaxel View
None Taxol View
None Breast cancer with brain metastases View
None Triple Negative View
None Triple negative breast cancer (TNBC) View
None Herceptin 2 (HER2)-positive View
None HER2-negative View
None Metastatic brain tumors View